**Core Concept**
Kawasaki disease is a medium-vessel vasculitis that predominantly affects children, characterized by a distinct clinical presentation and laboratory findings. It is a leading cause of acquired heart disease in children.

**Why the Correct Answer is Right**
Thrombocytopenia is not a characteristic feature of Kawasaki disease. In fact, thrombocytosis (an elevated platelet count) is often observed in the acute phase of the disease. This is due to the body's inflammatory response and the release of platelet-derived growth factor. The correct laboratory findings in Kawasaki disease include elevated erythrocyte sedimentation rate (ESR), elevated C-reactive protein (CRP), and anemia of chronic disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** Immunoglobulin therapy is indeed a treatment of choice for Kawasaki disease, especially in the presence of coronary artery aneurysms. It has been shown to reduce the incidence of coronary artery complications.
* **Option B:** The prognosis of Kawasaki disease is generally good, especially with prompt and aggressive treatment. However, coronary artery complications can occur, particularly if left untreated or if treatment is delayed.
* **Option D:** Elevated ESR is a characteristic laboratory finding in Kawasaki disease, reflecting the underlying inflammatory process.

**Clinical Pearl / High-Yield Fact**
Kawasaki disease is a clinical diagnosis, and laboratory findings are supportive. The American Heart Association (AHA) criteria for Kawasaki disease include fever for at least 5 days, bilateral conjunctival injection, cervical lymphadenopathy, rash, and changes in the lips and oral mucosa.

✓ Correct Answer: C. Thrombocytopenia